Introduction {#sec1-1}
============

Leishmaniasis is a vector-borne and zoonotic disease \[[@ref1]\] and is considered a neglected illness \[[@ref2]\]. This disease is caused by a protozoan parasite called Leishmania from the Trypanosomatidae family and Leishmania genus \[[@ref3]\]. This disease is transmitted to humans or animals by the bite of a female insect called sandflies from the Psychodidae family \[[@ref4]\]. Dogs and rodents are the main reservoirs of this disease \[[@ref5]\]. Leishmaniasis has three main clinical forms, namely Visceral leishmaniasis (VL) (Kala-azar), Cutaneous Leishmaniasis (CL) and Mucocutaneous leishmaniasis (MCL) \[[@ref6]\], \[[@ref7]\]. In this regard, the CL is a very common form and has the highest prevalence in the world \[[@ref8]\], So that the World Health Organization (WHO) has introduced this disease as an important neglected tropical disease. About 350 million people per year are exposed to this disease, and new cases are emerging annually \[[@ref9]\]. In 2017, the WHO reported 94% of new cases from seven countries, Brazil, Ethiopia, India, Kenya, Somalia, Sudan, and South Sudan. The highest number of CL are also reported in Afghanistan, Algeria, Brazil, Colombia, Pakistan, Peru, Saudi Arabia, Syria and Iran \[[@ref10]\]. In Iran, the CL is found in two types, namely Anthroponetic Cutaneous Leishmaniasis (ACL) and Zoonotic Cutaneous Leishmaniasis (ZCL) \[[@ref9]\], \[[@ref11]\] that are transmitted mainly by parasites, namely Leishmania (L.) major and L. tropica, Phlebotomus (Ph.) papatasi and ph. sergenti sandflies as the main vectors of this disease \[[@ref12]\]. The main reservoirs of urban form are humans with CL and occasionally dogs; and rural form reservoirs are mainly desert rodents such as Rombomis opimus, Meriones lybicus, and tatera indica \[[@ref13]\]. CL which is popularly known as Salak in Iran.

According to reports of the Center for Disease Control and Prevention, the number of people with Leishmaniasis in Iran is more than 20,000 per year \[[@ref14]\]. CL is an important health problem in more than 15 provinces of Iran. Nearly 88 cities in Iran have been diagnosed with this disease, and the most frequent reports are related to ZCL \[[@ref14]\]. The disease is endemic in many regions of Iran. Due to the increased prevalence of the disease in Iran, northeastern regions including Khorasan Razavi such as Neyshabur and Mashhad have had the emergence of new foci of this disease. The eastern regions of Iran, including the vast Neyshabur region with its numerous villages, have long been considered as a focus of the CL \[[@ref15]\]. Although CL is no lethal disease, it has always been taken into consideration due to the more involvement of patients with skin lesions and its long-term treatment \[[@ref16]\].

Various factors contribute to the incidence of disease, including climatic changes, environmental conditions, occupation, gender, and reduced vegetation cover. Furthermore, agricultural expansion, urban migration, and marginalisation contribute to the transmission of vector and parasitic of disease to new areas and increase the risk of this disease \[[@ref17]\]. The incubation period of ACL is up to 8 months, and it is less than 4 months for ZCL. After the incubation period, painless red papules appear in the sandfly bite location; and the lesion grows after a few weeks to several months, and dimples at a depth of 1 mm appear with the secretion of liquids \[[@ref18]\]. Treatment of leishmaniasis is based on the national protocol using Antimony (Sb5+) compounds such as Glucantime (intramuscular injection of 50 mg/kg of body weight, 10 ml per day for two to three weeks).

Patients should be examined and monitored by physicians for up to three weeks after the start of treatment to three months after healing. The injection of Glucantime into the lesion should be performed three times a week until the complete recovery \[[@ref19]\]. Since CL treatment needs a lot of time and it is associated with several adverse effects such as arrhythmia, increasing of liver enzymes, anaemia, thrombocytopenia and leukopenia \[[@ref20]\], Even if left untreated, the disease leads a fatality rate 95%-100% within 2 years \[[@ref21]\], therefore the use of effective measures to prevent the disease is important and requires the identification of vulnerable groups and epidemiologic agents that are effective in the disease in these areas. Given the increased cases of the disease in northeastern villages of Iran, especially in Neyshabur and its villages, the present study sought to evaluate the incidence of disease in this county in recent years, so that more effective control strategies could be adopted to reduce disease by identifying related factors of disease.

Material and Methods {#sec1-2}
====================

Geographical area {#sec2-1}
-----------------

Neyshabur County is a city in the central part of Razavi Khorasan and is located between 58° 19' and 59° 30' longitude and 35° 40' to 36° and 39' latitude in the eastern margin of the central desert of Iran \[[@ref22]\]. The vast majority of this city is located in a relatively large plain that is limited to Chenaran and Quchan counties from the north (by the Binalud Mountains); Mashhad County from the east; Torbat Heydarieh and Kashmar from the south; Sabzevar from the west; and Farooj County from the northwest in North Khorasan province. Neyshabur is located 110 kilometres west of Mashhad (Center of the Khorasan Razavi province) and 768 kilometres east of Tehran (Capital of Iran). The size of Neyshabur county is 8,722 square kilometres, which is equal to 2.9 percent of the area of Khorasan and 53 percent of the total area of Iran. Due to the population of Neyshabur with 451,780 people in the last census in 2016, it is the second-most populous city in Khorasan Razavi province \[[@ref23]\].

![Geographical location of Neyshabur county, Khorasan Razavi province, East Iran](OAMJMS-7-3710-g001){#F1}

Data collection and analysis {#sec2-2}
----------------------------

In this cross-sectional analytical study, the statistical population consisted of all individuals (971 cases of CL) who who had medical records in the health centers of Neyshabur and were diagnosed with CL according to the laboratory confirmation in Neyshabur county and its villages during 2011-2017; and their data were recorded in a health record by health care workers. Diagnostic methods were smear, culture. The necessary data including age, sex, place of residence (urban and rural), month and season of disease, incidence, number and location of lesions and some other important factors were extracted from their cases and then centres. The records that did not have the necessary data such as age, sex, job, diagnosis date and place of residence were removed from the study. To observe ethics in research, their full name and, father name and national code of all patients were removed from information files. For data analysis, data were first categorised into appropriate groups. After grouping and preparing data, the whole data was analysed using SPSS V.22. Chi-square test was used to analyse data, and the alpha value less than 0.05 was considered as the significance level.

Results {#sec1-3}
=======

The research results indicated that during the 7 years (2011-2017), a total of 971 cases of CL were reported. The highest incidence of CL was estimated in 2017 (44.7 per 100,000) and the least in 2015 (19.5 per 100,000) according to the population of Neyshabur in 2016 census ([Fig. 2](#F2){ref-type="fig"}).
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Of these, 469 (48.3%) were female, and 502 (51.7%) were male. The chi-square test showed that there was no significant association between sex and the disease (P \> 0.05). In Neyshabur villages, the CL was more common among men 246 (56.7%) versus 188 (43.3%) females but unlike villages, more women were affected in Neyshabur city 281 (52.3%) women versus 256 (47.7%) males, however, there was no significant difference between men and women in the incidence of CL in the city (P \> 0.05), while the difference was statistically significant in the village (P \< 0.001).

The mean and standard deviation of patients' age was 29.4 ± 19.3. The youngest patient was under the age of one, and the oldest was 90 years old. Less than a quarter of patients were above 42 years of age, and more than half of the patients were under the age of 28. The prevalence of CL was statistically significant in different age groups (P \< 0.001) ([Table 1](#T1){ref-type="table"}).

###### 

Distribution of CL disease characters in 971 patients in the city of Neyshabur, in 2011-2017

  *Characters/Years*                            *2011*                *2012*   *2013*   *2014*   *2015*   *2016*   *2017*   *Total (%)*   
  --------------------------------------------- --------------------- -------- -------- -------- -------- -------- -------- ------------- ------------
  Age Groups                                    0-10 Year             18       19       18       10       34       64       38            201 (20.7)
  11-20 Year                                    26                    25       18       22       14       26       20       151 (15.6)    
  21-30 Year                                    36                    33       42       15       17       25       17       185 (19.1)    
  31-40 Year                                    26                    22       22       17       23       47       22       179 (18.4)    
  41-50 Year                                    12                    18       9        13       16       37       7        112 (11.5)    
  \>50 Year                                     25                    20       6        23       15       30       24       143 (14.7)    
  Total                                         143                   137      115      100      119      229      128      971 (100)     
  P-Value                                       0.016                 0.237    0.000    0.170    0.012    0.000    0.000    0.000         
  *Sex*                                         Male                  76       75       75       49       62       105      60            502 (51.7)
  Female                                        67                    62       40       51       57       124      68       469 (48.3)    
  P-Value                                       0.452                 0.267    0.001    0.841    0.647    0.209    0.480    0.290         
  Habitat                                       Rural                 92       77       61       60       30       39       34            393 (40.5)
  Urban                                         51                    60       54       40       89       190      94       578 (59.5)    
  P-Value                                       0.001                 0.146    0.514    0.057    0.001    0.001    0.001    0.001         
  Session                                       Spring                29       26       27       25       13       65       30            215 (22.1)
  Summer                                        28                    28       20       26       12       43       26       183 (18.8)    
  Autumn                                        54                    59       41       29       30       56       39       308 (31.7)    
  Winter                                        32                    24       27       20       64       65       33       265 (27.3)    
  P-Value                                       0.005                 0.000    0.044    0.641    0.001    0.129    0.421    0.000         
  Treatment Type                                Systemic Glucantime   43       39       15       0        0        0        0             97 (10.0)
  Topical Glucantime                            99                    69       38       0        0        0        0        206 (21.2)    
  Topical Glucantime & Cryotherapy              1                     9        48       0        0        0        0        58 (6.0)      
  Cryotherapy                                   0                     20       14       2        1        4        1        42 (4.3)      
  Cryotherapy & Topical Antimoniate             0                     0        0        63       52       122      60       297 (30.6)    
  Topical Antimoniate                           0                     0        0        10       48       71       47       176 (18.1)    
  Systemic Antimoniate                          0                     0        0        25       18       32       20       95 (9.8)      
  Duration of systemic treatment                7-10                  10       10       1        2        0        0        1             24 (2.5)
  11-14                                         5                     6        2        4        2        0        6        25 (2.6)      
  15-18                                         1                     3        5        14       3        0        1        27 (2.8)      
  19-21                                         27                    20       7        5        13       32       11       115 (11.8)    
  Duration of Topical & Cryotherapy treatment   1-4                   2        12       4        27       31       46       2             124 (12.8)
  5-8                                           85                    75       81       48       45       81       60       454 (48.9)    
  9-12                                          13                    11       15       0        25       70       47       154 (18.6)    
  Occupation                                    Driver                4        2        1        4        1        4        3             19 (2.0)
  Worker                                        14                    7        11       6        4        6        4        52 (5.4)      
  Employer                                      3                     7        5        2        5        23       11       56 (5.8)      
  Farmer                                        22                    20       17       10       5        6        7        87 (9.0)      
  Student                                       24                    21       19       19       26       46       33       188(19.4)     
  Military                                      1                     1        10       0        0        0        6        18 (1.9)      
  housewife                                     49                    46       21       38       34       64       35       287 (29.6)    
  Baby                                          13                    14       10       19       42       74       21       193 (19.9)    
  self-Employment                               13                    19       21       2        2        6        8        71 (7.3)      
  P-Value                                       0.000                 0.000    0.000    0.000    0.000    0.000    0.000    0.000         
  Lesion Site                                   Hand                  95       88       80       76       78       146      71            634 (56.0)
  Feet                                          30                    35       31       23       37       73       20       249 (22.0)    
  Face                                          36                    29       15       17       28       68       41       234 (20.7)    
  Trunk                                         5                     1        3        0        2        0        4        15 (1.3)      
  Total                                         166                   153      129      116      145      258      136      1132 (100)    
  Travel history                                Haven't               89       62       40       42       60       133      84            510 (52.5)
  Have                                          54                    75       75       58       59       96       44       461 (47.5)    
  P-Value                                       0.003                 0.087    0.000    0.450    0.929    0.002    0.000    0.062         

Exactly 393 (40.5%) and 578 (59.5%) patients were rural and urban, respectively. There was a decreasing trend in the number of people with CL in villages and the increasing trend in the city from 2011 to 2017, and numbers of patients in the city and village were significantly different (p \< 0.001) in all years except for 2013 and 2014; and number of patients in cities was always higher than the villages. Considering the number of the rural population (N = 201,492) and the urban population (N = 311,256) in Neyshabur in 2017, the prevalence of the disease in the city (31 per hundred thousand) was about twice as high as the village (16.6 per hundred thousand).

In terms of geological division, people living in the north of the city (n = 340 patients) and southern villages (n = 195 patients), were more susceptible to CL, but those living in Northern villages (n = 35 patients) and southern city (n = 42) were less prone to CL ([Fig. 3](#F3){ref-type="fig"}).
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Regarding the seasonal tendency, the highest and lowest number of patients with CL belonged to autumn 308 (31.7%) and summer 183 (18.8%), and there was a significant different incidence in different seasons during 2011, 2012 and 2015, but no difference was seen in the rest of years, but generally there was a significant difference in the incidence of disease in different seasons (P \< 0.001). The highest prevalence was seen in April, October, November, and December in rural areas, and November, December, January, and February in urban areas.

According to research findings, in all examined years, the incidence of CL among those, who had travelled to other cities during the last year, was 510 (52.5%) compared to those who had not traveled 461 (47.5%) and they were not significantly different (P = 0.062), while the incidence of disease was greater and significantly different among non-travellers in 2011, 2013, 2016 and 2017.

Most of the patients with CL were housewives 287 (29.6%), children 193 (19.9%) and the least of them had military occupation 18 (2.0%). There was a statistically significant difference between the incidence of disease and multiple occupations in all years (P \< 0.001).

In this study, the location of the lesion was different in patients' bodies. The most commonplace of the lesion was on hands (56.0%), legs (22.0%), face (20.7%) and trunk (1.3%). The size of lesions was 2.7 ± 1.6 centimetres on average, and 47.0% were less than 1 cm, and 38.9% (1-4 cm); and only 14.0% of lesions were greater than 4 cm. The greatest lesion size was 11 cm (2.0%).

Most of the patients (80.2%) were treated by topical method, and 192 (19.8%) patients were treated using the systemic method. The duration of treatment in 608 (62.7%) of patients, who were treated by topical and combination of cryotherapy and topical methods, was 5-8 weeks or more. Patients treated with systemic methods had a shorter duration of treatment ([Table 1](#T1){ref-type="table"}).

Discussion {#sec1-4}
==========

The present study aimed to provide and analyse epidemiological information about CL in Neyshabur county during the last 7 years (2011-2017). During this period, a total of 971 cases of CL referred to health centres of the Neyshabur and were treated. Over the years, the overall incidence of CL did not change significantly in Neyshabur, and it also seemed to be a public health problem. Medium prevalence of CL in Neyshabur county (27.05 per 100,000) was almost equal to the average prevalence in Iran (27.5 per 100,000) based on the results of studies \[[@ref24]\].

In this study, both sexes were susceptible to CL disease; and the results of the study did not show any significant relationship between gender and disease (P = 0.29). Studies in Iran in cities, such as Kermanshah, Kashan, and Fars province reported similar findings \[[@ref25]\], \[[@ref26]\], \[[@ref27]\] but studies in Fasa city of Fars province and Jahrom different reports \[[@ref28]\], \[[@ref29]\].

Based on findings of the study in terms of age, the minimum age of 7 months and the highest age of 90 years had CL; the highest frequency (20.7%) was observed in the age group of 0-10 years probably due to the higher prevalence among the students. Our findings were inconsistent with studies in Kashan, Kermanshah and Fars \[[@ref25]\], \[[@ref26]\], \[[@ref27]\]. Based on analyses, prevalence in age groups depended on the residence (p \< 0.04, ρ (Spearman Correlation) *=* -0.031), gender (p \< 0.001, ρ = 0.105) and occupation (p \< 0.001, ρ = -0.091).

The incidence of disease in urban regions (59.5%) was higher than in rural regions (40.5%), and a significant difference was found between habitat in terms of the prevalence of CL (P \< 0.001). Results of our study were inconsistent with a study by Doroodgar in Kashan \[[@ref26]\] and Mohammadi's study in Marvdasht \[[@ref30]\] and a study by Rahmanian in Jahrom; there was a higher prevalence in villages \[[@ref29]\]. Due to its increasing prevalence in urban areas relative to rural areas, there was a need for health and education measures in these regions.

In terms of geographical division, the majority of patients lived in the north of the city (35%) and western villages (20%) of Neyshabur; and rates of CL were in statistically different in various geographical regions (p \< 0.001), probably due to amounts of building waste and public health conditions in those areas. Since the rate of disease increased in the north of the city and western villages during 2011-2017, it indicated the source of infection and appropriate growth conditions for cause of CL.

Seasonal trend study indicated that the highest prevalence of the disease was in autumn, especially November/December in Neyshabur and its villages. It seems that the incubation period of disease begins due to cool weather in autumn, and sandflies' peak activities and sucking the victims' blood reach their peak in the winter, and then their activity is slowly decreasing. Our results were consistent with findings in Kashan, Qom, Fars, and Yazd in terms of more prevalence in autumn \[[@ref26]\], \[[@ref31]\], \[[@ref32]\], but they were inconsistent with findings of Kermanshah in terms of more prevalence of the disease in winter \[[@ref25]\].

In the field of occupational groups, the highest prevalence was seen in housewives (27.1%), students (18.9%) and infants (19.3) due to staying more at home and their clothing styles, and more activity of sandflies in wet places \[[@ref33]\]. Also it may be due to higher number of housewives group in population. In men, the prevalence of disease was higher in farmers (8.5%), workers (5.4%) and self-employment (7.3%) due to their location in endemic regions, inadequate health information, and a significant difference in the incidence of disease and type of occupation (P \< 0.001). In a study by Doroodgar et al., (2018), the prevalence of disease was higher in housewives \[[@ref26]\] and in a research by Rahmanian et al., \[2018\] in the southwest of Iran, the highest prevalence was seen in students (28.8%), and there was a significant statistical difference between occupations in terms of prevalence of CL (p \< 0.001) \[[@ref29]\].

Based on findings of the present study, 95% of lesions were dry and without secretion, and were seen in all organs of the body such as (hands, arms, feet, trunk, face, forearm, legs, head and neck). In this study, hands (56%) had the highest bite reporting; and the location of the lesion was probably associated with the body cover. Face (32%) in women and hands and arms (31%) in men were the most involved locations. The average size of lesions was (2.2 ± 1.6 cm), and the smallest one was 1 cm, and the biggest one was 11 cm, and the average number of lesions was 2 ± 1.9 and the highest was 18. Rahmanian et al., (2018) reported the maximum number of lesions as 30 lesions in their study in Jahrom, southwestern Iran. This finding may be different due to the types and behaviour of insect blood-feeding, the number of bites feeding by sandflies per feeding time, and the frequency of infectious sandflies in that region \[[@ref29]\].

In conclusion, according to the results of the present study, the incidence of CL in Neyshabur was higher in north and west regions; and autumn was a more suitable season for the prevalence of CL in the region. Most patients were housewives, children under the age of ten, and people living in the city. Therefore, measures should be taken to improve environmental health, public health education, and making people aware of the positive impact of early diagnosis to achieve successful treatment by public health authorities and control the disease. Due to multiple lesions with different sizes in this disease, the likelihood of scar is higher, and thus the future studies should investigate the status of these scars and their causes. As the incidence of disease increased in the county in 2017, further studies should be conducted to clarify its causes.
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